The multiple myeloma research foundation's evolving focus on drug R & D

Nature Biotechnology

Volumn 30, Issue 7, 2012, Pages 600-603

  Giusti, Kathy ^a  

^a Multiple Myeloma Research Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE;

CANCER SURVIVAL; DRUG INDUSTRY; FINANCIAL MANAGEMENT; GENE MUTATION; MEDICAL RESEARCH; MULTIPLE MYELOMA; NOTE; ORGANIZATION; PRIORITY JOURNAL;

DRUG DISCOVERY; FOUNDATIONS; HUMANS; MULTIPLE MYELOMA; ORGANIZATIONS, NONPROFIT; RESEARCH;

EID: 84863676213     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.2297     Document Type: Note

References (3)

1. Dilts, D. & Sandler, A. J. Clin. Oncol. 24, 4545-4551 (2006).
2. Wear, S. et al. Proc. American Society of Hematology, San Diego, CA, Dec. 2011 (Abstract #1024)
3. Chapman, M.A. et al. Nature 471, 467-472 (2011).